Dr. Joseph Stephen Brigance, MD

Dr. Brigance practices at Crestwood Medical Center in Huntsville, Alabama, part of Huntsville Hospital Health System.

Dr. Brigance's NPI, 1003094293, was assigned on February 10, 2008. Dr. Brigance graduated from University of Louisville School of Medicine in 2003. Dr. Brigance holds Alabama license MD.34402.

Dr. Brigance's primary practice is Crestwood Medical Center, at One Hospital Dr SE, Huntsville, AL 35801 in Madison County. The practice phone is (256) 429-4000. Dr. Brigance also practices at Crestwood Medical Center, 1 Hospital SW Dr, Huntsville, AL 35801.

Dr. Brigance's primary practice is Crestwood Medical Center in Huntsville, Alabama, part of Huntsville Hospital Health System. Dr. Brigance is also affiliated with Huntsville Hospital. The medical group on file is Ear, Nose, Throat, Head & Neck Surgery of Huntsville. Dmand AI also links Dr. Brigance to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brigance practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Brigance's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dmand AI has Dr. Brigance's licenses on file in 2 states: Alabama and Indiana.

CMS data shows 941 Medicare services from Dr. Brigance across 11 procedure codes in 2024, for 315 Medicare patients. Medicare paid $59,097 for them. Every service was in an office.

CMS counts 315 Medicare patients who saw Dr. Brigance in 2024. The largest group is 65 to 74, with 146 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Brigance's median patient age at 63, with 51% women.

In 2024, Dr. Brigance wrote 469 Medicare Part D claims for 141 patients. 93% of them were for generic drugs. CMS names the drug for 381 of them, across 12 drugs with 11 or more claims each, at $4,547 in total drug cost. In 2023, CMS named 270 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Brigance for performance year 2024, reported as part of a group. Dr. Brigance accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 23 procedures of melanoma (skin cancer) excision by Dr. Brigance, more than 76% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 153 general payments to Dr. Brigance from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Acclarent, Inc paid the most, $698.

Dr. Brigance graduated from University of Louisville School of Medicine in 2003.